#China Biotech

Total 2 articles

Abstract visualization of global investment in biotech

BlackRock Investment in Chinese Biotech 2026: Global Funds Double Down

Global institutional investors, including BlackRock and Temasek, are securing major stakes in China's top biotech firms in 2026. Explore the strategic motivations.

Jan 23, 2026

The modern interior of a USTC laboratory in China

PoliticsEN

Renowned Immunologist Andrew Macpherson Joins China's USTC as Brain Drain Reverses

European immunologist Andrew Macpherson has joined China's USTC full-time. Explore how this move signals China's rise as a global hub for biomedical research.

Jan 11, 2026